Bolagao, Daniel C.
HRN: 25-29-34 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/09/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/09/2024
11/16/2024
IV
130mg
Q6h
PCAP
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes